Manufacturer record
Hindustan Laboratories Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
25 batches manufactured by Hindustan Laboratories Limited (Maharashtra) were declared Not of Standard Quality between December 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: THE26003AL, Pantoprazole Gastro Resistant Tablets IP 40 mg (exp Mar 2028). SDTL, Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Dissolution Test. Listed in the September 2026 alert.
Records by type
25 records linked to Hindustan Laboratories Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro Resistant Tablets IP 40 mg | Batch THE26003ALMfg Apr 2026 · Exp Mar 2028 | Dissolution TestDissolution | SDTL, Andhra Pradesh, VijayawadaState lab | Sep 2026 |
| Dicyclomine Tablets I.P 10 mg | Batch THY25008AMfg May 2025 · Exp Apr 2027 | DescriptionDescription | RDTL, Hubli, KarnatakaState lab | Sep 2026 |
| Aspirin Tablets IP 150mg | Batch TAS25011ALMfg Jun 2025 · Exp May 2027 | DissolutionDissolution | Drug Testing Laboratory, Chennai-6State lab | Sep 2026 |
| Iron and Folic Acid IP (Large) | Batch TCW25029ALMfg Nov 2025 · Exp Oct 2027 | The Content of Folic Acid in the Sample is less (i.e.62.36% of stated Amount) than the I.P. Limit. (I.P. Limit- Not less than 90% of the stated Amount)Other | FDAL, MumbaiState lab | Aug 2026 |
| Povidone-Iodine Ointment USP 5% w/w | Batch EP25081ALMfg Oct 2025 · Exp Sep 2027 | The sample does not conform to claim as per USP 2025 in respect to the Assay of Povidone-Iodine as Available IodineAssay | RDTL, ChandigarhCDSCO lab | Jun 2026 |
| Dicyclomine Tablets IP 10 mg | Batch THY25005ALMfg Apr 2025 · Exp Mar 2028 | Sample does not conform to IP standards with respect to Description.Description | RDTL ErnakulamState lab | Jun 2026 |
| Telmisartan Tablets IP 40 mg | Batch TEP25086ALMfg Apr 2025 · Exp Mar 2027 | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | May 2026 |
| Dicyclomine Tablets IP | Batch THY25001ALMfg Jan 2025 · Exp Dec 2027 | DescriptionDescription | RDTL, ErnakulamState lab | Mar 2026 |
| Glipizide Tablets IP 5 mg | Batch TCY24030ALMfg Dec 2024 · Exp Nov 2026 | DescriptionDescription | DTL, Madurai-19State lab | Feb 2026 |
| Iron and folic acid syrup IP | Batch LAV25159ALMfg Aug 2025 · Exp Oct 2026 | DescriptionDescription | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Telmisartan Tablets IP 40MG | Batch TEP25123ALMfg May 2025 · Exp Apr 2027 | The sample does not confirm to IP 2022 requirement with respect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir (J & K)State lab | Dec 2025 |
| Paracetamol Tablets IP 650mg | Batch TEM24011ALMfg Oct 2024 · Exp Sep 2026 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| FOLIC ACID TABLETS IP 5mg (FOLIC ACID TABLETS IP 5mg) | Batch TFN25012ALMfg Jul 2025 · Exp Jun 2027 | Uniformity of contentUniformity of weight/content | SDTL, PunjabState lab | Oct 2025 |
| Telmisartan Tablets I.P. (20 mg) | Batch TFI24009ALMfg Aug 2024 · Exp Jul 2026 | DescriptionDescription | MDTL Kathua ( J&K)State lab | Sep 2025 |
| Paracetamol Tablets IP 650 mg | Batch TEM25002ALMfg Mar 2025 · Exp Feb 2025 | DissolutionDissolution | DTL/BaddiState lab | Sep 2025 |
| Telmisartan Tablets I.P. (20 mg) | Batch TFI24009ALMfg Aug 2024 · Exp Jul 2026 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Dicyclomine Tablets IP | Batch THY24010ALMfg Aug 2024 · Exp Jul 2026 | Description.Description | DTL MaduraiState lab | Jun 2025 |
| Diclofenac Sodium Tablets IP | Batch THB24028ALMfg Jul 2024 · Exp Jun 2026 | Sample does not conform to IP specification for Enteric Coated Tablets with respect to DisintegrationDisintegration | DTL ChennaiState lab | Apr 2025 |
| Aspirin Tablets | Batch TAS2301 0ALMfg Oct 2023 · Exp Sep 2025 | Sample does not conform to IP Specification for Aspirin Tablets with respect to the content of Aspirin.Other | DTL MaduraiState lab | Jan 2025 |
| Diphenhydramine HCl, Ammonium- Chloride and Sodium Citrate Cough Expectorant | Batch LDS2005ALMfg Dec 2022 · Exp May 2024 | Assay of MentholAssay | RDTL ChandigarhCDSCO lab | Mar 2023 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg | Batch TDJ2010ALMfg Mar 2022 · Exp Aug 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| ZINC SULPHATE DISPERSIBLE TABLETS IP 20 mg | Batch TAC0006ALMfg Jun 2020 · Exp May 2022 | Disintegration TestDisintegration | RDTL GuwahatiCDSCO lab | Apr 2021 |
| Calcium with Vitamin D3 Tablets | Batch TAK8048ALMfg Apr 2018 · Exp Mar 2020 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
| Calcium with Vitamin D3 Tablets | Batch TAK8162ALMfg Jun 2018 · Exp May 2020 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
| Calcium with Vitamin D3 Tablets | Batch TAK8137ALMfg Jun 2018 · Exp May 2020 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.